15234398

Source:http://linkedlifedata.com/resource/pubmed/id/15234398

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0009566, umls-concept:C0190211, umls-concept:C0247025, umls-concept:C0442796, umls-concept:C0475224, umls-concept:C0725066, umls-concept:C1511237, umls-concept:C1521801, umls-concept:C1522609, umls-concept:C1550436, umls-concept:C1554112, umls-concept:C1705509, umls-concept:C1708528
pubmed:issue	1
pubmed:dateCreated	2004-7-5
pubmed:abstractText	We sought to determine the safety and efficacy of high-dose bolus (HDB) tirofiban in high-risk patients undergoing percutaneous coronary intervention (PCI).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase, MB Form, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Troponin I, http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine, http://linkedlifedata.com/resource/pubmed/chemical/tirofiban
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0735-1097
pubmed:author	pubmed-author:BarbieriDarioD, pubmed-author:FerrariFabrizioF, pubmed-author:FerrariRobertoR, pubmed-author:GuardigliGabrieleG, pubmed-author:ParrinelloGiovanniG, pubmed-author:PercocoGianfrancoG, pubmed-author:SoukhomovskaiaOlgaO, pubmed-author:ValgimigliMarcoM
pubmed:issnType	Print
pubmed:day	7
pubmed:volume	44
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	14-9
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15234398-Acute Disease, pubmed-meshheading:15234398-Aged, pubmed-meshheading:15234398-Angioplasty, Balloon, Coronary, pubmed-meshheading:15234398-Anticoagulants, pubmed-meshheading:15234398-Biological Markers, pubmed-meshheading:15234398-Coronary Stenosis, pubmed-meshheading:15234398-Creatine Kinase, pubmed-meshheading:15234398-Creatine Kinase, MB Form, pubmed-meshheading:15234398-Dose-Response Relationship, Drug, pubmed-meshheading:15234398-Double-Blind Method, pubmed-meshheading:15234398-Female, pubmed-meshheading:15234398-Heparin, pubmed-meshheading:15234398-Humans, pubmed-meshheading:15234398-Intraoperative Complications, pubmed-meshheading:15234398-Isoenzymes, pubmed-meshheading:15234398-Male, pubmed-meshheading:15234398-Middle Aged, pubmed-meshheading:15234398-Myocardial Ischemia, pubmed-meshheading:15234398-Platelet Aggregation Inhibitors, pubmed-meshheading:15234398-Prevalence, pubmed-meshheading:15234398-Risk Factors, pubmed-meshheading:15234398-Syndrome, pubmed-meshheading:15234398-Treatment Outcome, pubmed-meshheading:15234398-Troponin I, pubmed-meshheading:15234398-Tyrosine
pubmed:year	2004
pubmed:articleTitle	The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.
pubmed:affiliation	Department of Cardiology, University of Ferrara, Ferrara, Italy. vlgmrc@unife.it
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't